These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 470544)
21. [Effect of repeated haloperidol and apomorphine administration on the development of tolerance for catalepsy and dopamine receptor hypersensitivity in mice]. Zharkovskiĭ AM; Matvienko OA; Nurk AM Biull Eksp Biol Med; 1984 Oct; 98(10):444-6. PubMed ID: 6541951 [TBL] [Abstract][Full Text] [Related]
22. The effect of dopamine receptor agonist treatment on haloperidol-induced supersensitivity in mice. Fayle P; Jackson DM; Jenkins OF; Lafferty PA Pharmacol Biochem Behav; 1985 Nov; 23(5):715-20. PubMed ID: 4080755 [TBL] [Abstract][Full Text] [Related]
23. Dopamine receptor changes in response to prolonged treatment with L-dopa. Groppetti A; Flauto C; Parati E; Vescovi A; Rusconi L; Parenti M J Neural Transm Suppl; 1986; 22():33-45. PubMed ID: 2946813 [TBL] [Abstract][Full Text] [Related]
24. Chronic neuroleptic treatment in rats produces persisting changes in GABAA and dopamine D-2, but not dopamine D-1 receptors. See RE; Aravagiri M; Ellison GD Life Sci; 1989; 44(3):229-36. PubMed ID: 2536879 [TBL] [Abstract][Full Text] [Related]
25. Coexistence of severe parkinsonism and tardive dyskinesia as side effects of neuroleptic therapy. Bitton V; Melamed E J Clin Psychiatry; 1984 Jan; 45(1):28-30. PubMed ID: 6141157 [TBL] [Abstract][Full Text] [Related]
26. The effect of ethanol and haloperidol on dopamine receptor (D2) density. Fuchs V; Coper H; Rommelspacher H Neuropharmacology; 1987 Aug; 26(8):1231-3. PubMed ID: 3658125 [TBL] [Abstract][Full Text] [Related]
27. Changes in apomorphine-induced stereotypy as a result of subacute neuroleptic treatment correlates with increased D-2 receptors, but not with increases in D-1 receptors. Fleminger S; Rupniak NM; Hall MD; Jenner P; Marsden CD Biochem Pharmacol; 1983 Oct; 32(19):2921-7. PubMed ID: 6138043 [TBL] [Abstract][Full Text] [Related]
28. Chronic domperidone fails to increase striatal spiperone binding sites despite hyperprolactinemia: comparison with chronic haloperidol. Morgan DG; Sinha YN; Finch CE Neuroendocrinology; 1984 May; 38(5):407-10. PubMed ID: 6728123 [TBL] [Abstract][Full Text] [Related]
29. Enhanced striatal 3H-spiroperidol binding induced by chronic haloperidol treatment inhibited by peptides administered during the withdrawal phase. Bhargava HN Life Sci; 1984 Feb; 34(9):873-9. PubMed ID: 6142397 [TBL] [Abstract][Full Text] [Related]
30. Neuroleptic-induced striatal dopamine receptor supersensitivity in mice: relationship to dose and drug. Severson JA; Robinson HE; Simpson GM Psychopharmacology (Berl); 1984; 84(1):115-9. PubMed ID: 6149590 [TBL] [Abstract][Full Text] [Related]
31. The effect of drug holidays in an animal model of tardive dyskinesia. Bannet J; Belmaker RH; Ebstein RP Psychopharmacology (Berl); 1980; 69(2):223-4. PubMed ID: 6779315 [TBL] [Abstract][Full Text] [Related]
32. Dopamine receptors: effects of chronic L-dopa and bromocriptine treatment in an animal model of Parkinson's disease. Schneider MB; Murrin LC; Pfeiffer RF; Deupree JD Clin Neuropharmacol; 1984; 7(3):247-57. PubMed ID: 6435870 [TBL] [Abstract][Full Text] [Related]